Biopreservation Market Worth $4.9 Billion by 2025 – Exclusive Report by MarketsandMarkets(TM) – Stockhouse
stemadminStem Cell MedicineNo comments

CHICAGO, June 23, 2020 /PRNewswire/ -- According to the new market research report "Biopreservation Market by Type (Media (Sera), Equipment (Thawing Equipment, Alarms, Freezers)), Biospecimen (Human Tissue, Stem Cells, Organs), Application (Therapeutic, Research, Clinical Trials), End User (Hospitals, Biobank) - Global Forecast to 2025", published by MarketsandMarkets, the Biopreservation Market is projected to reach USD 4.9 billion by 2025 from USD 3.1 billion in 2020, at a CAGR of 9.1% between 2020 and 2025.

Read more
BIOBANKS MARKET COMPETITIVE LANDSCAPE ANALYSIS WITH FORECAST BY 2025 – 3rd Watch News
stemadminStem Cell MedicineNo comments

Global Biobanks Market: Overview The global biobanks market owes its conception to the rising need for replacement organs and the steady advancement in the replacement and transfusion technologies regarding a number of bodily substances. Though the technology and need to store organs and other bio-entities had been available for a long time, the global biobanks market took on a more important role in the healthcare sector following the increasing research in genomics.

Read more
Global Cord Blood Banking Market 2020 Production, Revenue, Average Product Price and Market Shares of Key Players 2025 – Jewish Life News
stemadminStem Cell MedicineNo comments

The study on the Cord Blood Banking Marketby Brand Essence Market Research is a compilation of systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also offers a precise analysis of the key challenges and growth prospects awaiting key players of the Cord Blood Banking market, including a concise summary of their corporate strategies and competitive setting

Read more
BrainStorm Expands Clinical Pipeline to Evaluate NurOwn for the Treatment of Alzheimer’s Disease | 2020-06-24 | Press Releases – Stockhouse
stemadminStem Cell MedicineNo comments

NEW YORK, June 24, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced a new clinical program focused on the development of NurOwn® as a treatment for Alzheimer's disease. As part of the newly announced program, the Company is planning a multi-national Phase 2 clinical trial to evaluate the safety and efficacy of NurOwn treatment in patients with prodromal to mild Alzheimer's disease.

Read more
Study gives insights into how human fat cells are affected by age – Mirage News
stemadminStem Cell MedicineNo comments

It was once thought that the fat cell was fairly inactive, but we suspect that its active and controls a lot more than previously thought, says Niklas Mejhert, co-senior author of the paper and joint group leader with Rydn at the Department of Medicine, Huddinge, Karolinska Institutet. If we can regulate the accumulation of fat in a more controlled way, it could bring huge advantages.

Read more
Cell and gene therapy-focused OpenCell Technologies hires MilliporeSigma executive Kevin Gutshall as new CEO – Webster County Citizen
stemadminStem Cell MedicineNo comments

ST. LOUIS, June 18, 2020 /PRNewswire/ -- OpenCell Technologies, an R&D-stage biomedical venture, has announced the hiring of Kevin Gutshall as CEO. Kevin leaves his role as MilliporeSigma's director of life science business development and M&A focusing on the cell and gene therapy business unit, to join OpenCell and lead its efforts to translate and commercialize its core technology platform, POROS.

Read more
Sernova Highlights Positive Results Presented at the American Diabetes Association’s Virtual 80th Scientific Sessions – TheNewswire.ca
stemadminStem Cell MedicineNo comments

LONDON, ONTARIO - TheNewswire - June 18, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-stage regenerative medicine therapeutics company, highlights positive results from its submitted abstract entitled "Clinical Validation of the Implanted Pre-Vascularized Cell Pouch(TM) as a Viable, Safe Site for Diabetes Cell Therapy," selected for presentation at the American Diabetes Association's (ADA) 80th Scientific Sessions held virtually June 12-16, 2020

Read more

Theme: Illdy.